Abstract
A synthesis of functionalized 2-aryl-4-(arylamino)quinazolines from 4-chloro-2-arylquinazolines (derived from 2-arylquinazolin-4(3H)-one) and 5-chloroaniline derivatives in DMF is described. The interaction of 2-aryl-4-(arylamino)quinazolines with their biological target, human epithelial growth factor receptor (EGFR), was investigated by molecular docking. Docking results indicated lower binding energy for all compounds towards EGFR active sites. The cytotoxic activities of fifteen 2-aryl-4-(arylamino)quinazolines are evaluated against lung adenocarcinoma (A549) and ovarian cancer (SKOV3) cell lines using MTT method. Our results demonstrated that among the tested compounds 2-(4-bromophenyl)-N-(5-chloro-2-methylphenyl)quinazolin-4-amine and N-(2,5-dichlorophenyl)-2-(4-chlorophenyl)quinazolin-4-amine showed desirable cytotoxic activities on both cell lines. Compounds 2-(3-bromophenyl)-N-(5-chloro-2-methylphenyl)quinazolin-4-amine and 2-(4-bromophenyl)-N-(2,5-dichlorophenyl)quinazolin-4-amine displayed appropriate cytotoxic activities on A549 and SKOV3 cell lines, respectively.
Graphical abstract
Similar content being viewed by others
References
Chandrika PM, Yakaiah T, Rao ARR, Narsaiah B, Reddy NC, Sridhar V, Rao JV (2008) Eur J Med Chem 43:846
Abdel-Gawad NM, Georgey HH, Youssef RM, El-Sayed NA (2010) Eur J Med Chem 45:6058
Lu L, Zhang M-M, Jiang H, Wang XS (2013) Tetrahedron Lett 54:757
El-Azab AS, Al-Omar MA, Alaa AM, Abdel-Aziz AA, Abdel-Aziz NI, El-Sayed MA, Aleisa AM, Sayed-Ahmed MM, Abdel-Hamide SG (2010) Eur J Med Chem 45:4188
Alagarsamy V, Raja Solomon V, Sheorey RV, Jayakumar R (2009) Chem Biol Drug Des 73:471
Huang C, Fu Y, Fu H, Jiang Y, Zhao Y (2008) Chem Commun 47:6333
Rajput R, Mishra AP (2012) Int J Pharm Pharm Sci 4:66
Wright SW, Carlo AA, Carty MD, Danley DE, Hageman DL, Karam GA, Levy CB, Mansour MN, Mathiowetz AM, McClure LD, McPherson RK, Pandit J, Pustilnik LR, Schulte GK, Soeller WC, Treadway JL, Wang IK, Bauer PH (2002) J Med Chem 45:3865
Chandregowda V, Kush AK, Reddy GC (2009) Eur J Med Chem 44:3046
Alagarsamy V, Pathak US (2007) Bioorg Med Chem 15:3457
Maruthamuthu M, Rajam S, Stella CR, Bharathi Dileepan AG, Ranjith R (2016) J Chem Pharm Res 8:505
Zein MA (2012) J Am Sci 8
Bedi PMS, Kumar V, Mahajan MP (2004) Bioorg Med Chem Lett 14:5211
Mishra AD (2012) Nepal J Sci Tech 12:133
Shewchuk L, Hassell A, Wisely B, Rocque W, Holmes W, Veal J, Kuyper LF (2000) J Med Chem 43:133
Marzaro G, Guiotto A, Chilin A (2012) Expert Opin Ther Pat 22:223
Sriram KB, Savarimuthu Francis SM, Tan ME, Bowman RV, Yang IA, Fong KM (2010) Curr Respir Med Rev 6:310
Rajasekaran A, Rajamanickam V, Darlinquine S (2013) Eur Rev Med Pharmacol Sci 17:95
Jiang JB, Hesson DP, Dusak BA, Dexter DL, Kang GJ, Hamel E (1990) J Med Chem 33:1721
Larksarp C, Alper H (2000) J Org Chem 65:2773
Akazome M, Yamamoto J, Kondo T, Watanabe Y (1995) J Organomet Chem 494:229
Abdel-Jalil RJ, Voelter W, Saeed M (2004) Tetrahedron Lett 45:3475
Jing XB, Li Z, Pan X, Shi YC (2008) J Chin Chem Soc 55:1145
Haghighijoo Z, Eskandari M, Khabnadideh S (2017) Med Res Arch 5:5
Haghighijoo Z, Rezaei Z, Taheri S, Jani M, Khabnadideh S (2015) Trends Pharm Sci 1:173
Khabnadideh S, Pez D, Musso A, Brun R, Pérez LMR, González-Pacanowska D, Gilbert IH (2005) Bioorg Med Chem 13:2637
Humphrey W, Dalke A, Schulten K (1996) J Mol Graph 14:33
Fereidoonnezhad M, Faghih Z, Mojaddami A, Sakhteman A, Rezaei Z (2016) Dent J 1:5
Fereidoonnezhad M, Faghih Z, Mojaddami A, Tabaei SMH, Rezaei Z (2016) J Sci Islam Repub Iran 27:39
Sun J, Wang XY, Lv PC, Zhu HL (2015) Sci Rep 5:13934
Li Z, Gu J, Zhuang H, Kang L, Zhao X, Guo Q (2015) Appl Soft Comput 26:299
Faghih Z, Neshat A, Wojtczak A, Faghih Z, Mohammadi Z, Varestan S (2017) Inorg Chim Acta 471:404
Fereidoonnezhad M, Niazi Ahmadipour T, Mirzaee Z, Faghih Z, Faghih Z, Shahsavari HR (2017) Eur J Inorg Chem 2017:2247
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Rahmannejadi, N., Khabnadideh, S. & Yavari, I. Synthesis, docking, and cytotoxic activities of novel 2-aryl-4-(arylamino)quinazolines. Monatsh Chem 149, 2085–2092 (2018). https://doi.org/10.1007/s00706-018-2270-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00706-018-2270-3